Palisades Park, NJ, United States of America

Essat Bilali

This inventor holds 1 USPTO granted patent. Top assignee: Block Drug Company, Inc.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Essat Bilali. Retrieved from https://idiyas.com/inventor/essat-bilali

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Essat Bilali

Introduction

Essat Bilali is a notable inventor based in Palisade Park, NJ (US). She has made significant contributions to the field of flavoring formulations, particularly in masking unpleasant tastes associated with certain compounds. Her innovative approach has led to the development of a unique patent that addresses a common challenge in oral formulations.

Latest Patents

Essat holds a patent for a "Flavor blend for masking unpleasant taste of zinc compounds." This invention features a synergistic flavoring combination of at least two flavoring oils and lauryl alcohol. It is designed for use in orally administered formulations containing ionizable zinc compounds, which often have undesirable tastes. The flavoring combination is unexpectedly effective in masking the unpleasant taste or aftertaste of zinc, making it a valuable addition to the field.

Career Highlights

Essat Bilali is currently associated with Block Drug Company, Inc., where she applies her expertise in flavor formulation. Her work focuses on enhancing the palatability of medicinal products, ensuring that patients have a more pleasant experience when taking oral medications.

Conclusion

Essat Bilali's innovative contributions to flavoring formulations demonstrate her commitment to improving the quality of oral medications. Her patent showcases her ability to address real-world challenges in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…